Skip to content

About & History

SITS – Safe Implementation of Treatments in Stroke, is a non-profit, research-driven, independent, international collaboration. It’s an initiative by the medical profession to assure excellence in acute treatment and secondary prevention of stroke, as well as to facilitate clinical trials.

  • SITS was founded

    SITS started as an initiative by participants in the European-Australian  randomised stroke thrombolysis studies (ECASS). SITS started as a registry for IV thrombolysis with alteplase.

Our Collaborators

Support and Funding

SITS is financed directly and indirectly by grants from Karolinska Institutet, Stockholm County Council, the Swedish Heart-Lung Foundation, the Swedish Order of St. John, Friends of Karolinska Institutet, and private donors, as well as from an unrestricted sponsorship from Boehringer-Ingelheim.

SITS has previously received grants from the European Union Framework 7, the European Union Public Health Authority and Ferrer Internacional.

SITS is currently conducting studies supported by Boehringer-Ingelheim and EVER Pharma, as well as in collaboration with Karolinska Institutet, supported by Stryker, Covidien, Phenox and Codman.

Scan the code